OPTN - OptiNose, Inc.
9.6
-0.110 -1.146%
Share volume: 860,961
Last Updated: 05-20-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$9.71
-0.11
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-14-2024 | 08-08-2024 | 11-12-2024 | 03-26-2025 | 05-14-2025 | |
| Assets | ||||||
| Total Assets | 83.707 M | 131.872 M | 131.020 M | 128.785 M | 114.854 M | |
| Current Assets | 81.122 M | 128.930 M | 128.215 M | 125.843 M | 112.006 M | |
| Inventories | 10.315 M | 11.407 M | 11.301 M | 11.463 M | 11.300 M | |
| Other Current Assets | 4.936 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 4.936 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 14.227 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 51.644 M | 91.358 M | 82.497 M | 84.485 M | 72.933 M | |
| Total Non-current Assets | 2.585 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 754.000 K | 714.000 K | 670.000 K | 605.000 K | 541.000 K | |
| Other Assets | 1.831 M | 2.228 M | 2.135 M | 2.337 M | 2.307 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 83.707 M | 131.872 M | 131.020 M | 128.785 M | 114.854 M | |
| Total liabilities | 182.923 M | 174.725 M | 172.117 M | 169.145 M | 176.220 M | |
| Total current liabilities | 32.705 M | 32.700 M | 162.430 M | 162.813 M | 175.008 M | |
| Accounts Payable | 1.912 M | 32.700 M | 36.445 M | 36.331 M | 32.143 M | |
| Other liabilities | 19.565 M | 16.732 M | 9.687 M | 6.332 M | 1.212 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 130.653 M | 125.293 M | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 19.565 M | 16.732 M | 9.687 M | 6.332 M | 1.212 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -99.216 M | -42.853 M | -41.097 M | -40.360 M | -61.366 M | |
| Common stock | 112.595 M | 699.255 M | 700.544 M | 701.641 M | 703.051 M | |
| Retained earnings | -734.443 M | -742.024 M | -741.557 M | -741.917 M | -764.333 M |